Leyden Labs

📍 Amsterdam, Netherlands🗓 Founded 2020👥 84 employees💰 Last funded Sep 2024
Biotechnology Research🌐 leydenlabs.com
Website LinkedIn
Leyden Labs aims to help people live their lives to the fullest. Our platform targets commonalities of viral families to protect humanity from known and future viruses. Our portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many variants of respiratory viruses, including ones in the influenza and coronavirus families. The Leyden Labs’ energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
1
United Kingdom
1
China
1
Investor activity2021–2024 · investors recorded per year
202112022120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Leyden Labs?
Leyden Labs has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Leyden Labs last raise funding?
The most recent investment in Leyden Labs recorded on gritt.io was in September 2024.
When was Leyden Labs founded?
Leyden Labs was founded in 2020.
What industry is Leyden Labs in?
Leyden Labs operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Leyden Labs based?
Leyden Labs is headquartered in Amsterdam, Netherlands.